Alesi Surgical Ltd, an innovative and multi-award-winning Irish company, has raised an impressive €5 million in funding to further advance its mission in women's health. Emerging from the BioInnovate Ireland initiative, Alesi Surgical is dedicated to addressing unmet clinical needs in the realm of obstetric surgery, a critical area that remains underdeveloped in medical technologies. This recent funding round will bolster their ongoing projects, particularly the continued development and commercialization of the SteriCISION C-Section Retractor, a pioneering tool developed in collaboration with the University of Galway. Alesi Surgical has achieved remarkable milestones since its inception, including receiving prestigious grants and accolades such as participation in the Blackstone-backed LaunchPad Lift accelerator and winning multiple awards at both national and international competitions. Their innovative solutions have already garnered recognition for significantly improving outcomes for mothers and newborns during surgical procedures. With this substantial financial backing, Alesi Surgical aims to enhance its research capabilities, scale production, and bring its cutting-edge technologies to a global market, ultimately fostering safer surgical experiences for women worldwide. The company has solidified its position as a trailblazer in MedTech innovation and looks poised to make a substantial impact in improving women's healthcare, reinforcing Ireland's growing reputation as a hub for health technology advancements. As Alesi Surgical continues to break boundaries, they remain committed to transforming the landscape of women's health and ensuring that every woman receives the quality care she deserves.








